Hepanova, Inc. is a clinical-stage global pharmaceutical company developing First-in-Class drug candidates for chronic liver diseases. The company was founded in 2014 in California and runs two state-of-the-art R&D Centers located in Gaithersburg, Maryland and Shanghai Zhangjiang Hi-Tech Park, China. The mission of Hepanova is to discover, develop and commercialize innovative therapeutics for chronic liver diseases with high unmet medical needs. Hepanova’s compelling pipelines include multiple R&D programs targeting at MASH (metabolic dysfunction-associated steatohepatitis, formerly known as NASH), liver fibrosis, and HCC (hepatocellular carcinoma). The First-in-Class MASH & liver fibrosis drug, HPN-01 is currently in U.S. Phase I clinical trial, showing promising early results. It is also the only MASH candidate targeting all major mechanisms – hepatic steatosis, inflammation, and fibrosis simultaneously, with strong efficacy data in all three conditions.
Company Details
- Employees
- 2
- Founded
- 2014
- Address
- 401 Professional Dr, Gaithersburg,maryland 20879,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.hepanova.com
- Keywords
- Drug discovery, Drug R&D, Liver disease, NAFLD/NASH, Hepatic fibrosis, Liver cancer, Antivirals, HBV, HCV, Cancer, Translational medicine, Innovative therapeutics, Disease prevention, Precision medicine, MASH.
- HQ
- Gaithersburg, Maryland
Hepanova, Inc. Questions
Hepanova, Inc.'s website is http://www.hepanova.com
Hepanova, Inc.'s LinkedIn profile is https://www.linkedin.com/company/hepanova-inc
Hepanova, Inc. has
2 employees.
View email and phone details for 2
employees at Hepanova, Inc..
Hepanova, Inc.'s industry is
Biotechnology Research
Hepanova, Inc.'s top competitors are
Wuxi Biologics,
Nutshell Therapeutics,
Eenzyme, Llc,
M7 Healthcare Accelerator,
Parker Institute For Cancer Immunotherapy,
Whichdoc,
H7 Biocapital,
Biokatalyst,
Cellicure, Inc.,
Akero Therapeutics.
Hepanova, Inc.'s categories are Biotechnology Research
Hepanova, Inc.'s founding year is 2014
